MCID: CCN001
MIFTS: 48

Cocaine Dependence malady

Category: Mental diseases

Aliases & Classifications for Cocaine Dependence

About this section

Summaries for Cocaine Dependence

About this section
Wikipedia:71 Cocaine dependence is a psychological desire to use cocaine regularly. Cocaine overdose may result in... more...

MalaCards based summary: Cocaine Dependence is related to antisocial personality disorder and schizophrenia. An important gene associated with Cocaine Dependence is DRD2 (Dopamine Receptor D2), and among its related pathways are Amphetamine addiction and Monoamine Transport. Affiliated tissues include brain, heart and testes, and related mouse phenotypes are adipose tissue and digestive/alimentary.

Disease Ontology:11 A drug dependence that is a psychological dependency on the regular use of cocaine.

Related Diseases for Cocaine Dependence

About this section

Diseases related to Cocaine Dependence via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 116)
idRelated DiseaseScoreTop Affiliating Genes
1antisocial personality disorder30.9DRD2, DRD3
2schizophrenia29.3DBH, DRD2, DRD3, PRL, SLC6A3, SLC6A4
3heroin dependence27.7DRD2, DRD3, OPRK1, OPRM1, PDYN, POMC
4cocaine intoxication10.9
5adult spinal cord ependymoma10.6DRD2, DRD3
6dissociative disorder10.6DRD3, SLC6A4
7erysipelas10.6DRD2, PRL
8strabismus10.6DRD2, PRL
9lipedematous scalp10.6DRD2, DRD3
10symmastia10.5DRD2, PRL
11dental fluorosis10.5SLC6A3, SLC6A4
12rabies10.5PRL, SLC6A4
13psychotic disorder10.5
14anosognosia10.5DRD2, SLC6A4
15mobitz type ii atrioventricular block10.5POMC, PRL
16bardet-biedl syndrome10.5POMC, PRL
17aneurysm or dilatation of ascending aorta10.5POMC, PRL
18lipid-rich carcinoma10.4POMC, PRL
19retinal microaneurysm10.4POMC, PRL
20irritant dermatitis10.4DRD2, SLC6A3
21lactic acidosis10.4POMC, PRL
22colloid carcinoma of the pancreas10.4POMC, PRL
23postpartum depression10.4POMC, PRL
24hypothalamic neoplasm10.4POMC, PRL
25basal cell carcinoma10.4DRD2, SLC6A3, SLC6A4
26splenic disease10.4DRD2, SLC6A3, SLC6A4
27asperger syndrome10.4DRD2, DRD3, SLC6A3
28tongue disease10.4DRD2, SLC6A3, SLC6A4
29pericoronitis10.4PDYN, POMC
30central retinal vein occlusion10.4POMC, PRL
31ulcerative colitis10.4DRD2, SLC6A4
32acute myeloid leukemia, kit-related10.4POMC, PRL
33hypothryoidism, congenital, nongoitrous 410.4POMC, PRL
34glutathionuria10.4POMC, SLC6A3
35immune system organ benign neoplasm10.4POMC, PRL
36osseous heteroplasia, progressive10.3POMC, PRL
37congenital epulis10.3POMC, PRL
38hypertrophy of breast10.3PRL, SLC6A3
39albinism, oculocutaneous, type v10.3DRD2, DRD3, SLC6A4
40polycystic kidney disease 210.3DBH, DRD2, SLC6A3
41osteogenesis imperfecta, type ix10.3DBH, DRD2, SLC6A3
42nonencapsulated sclerosing carcinoma10.3OPRK1, SLC6A4
43pelvic inflammatory disease10.3DBH, DRD2, SLC6A4
44vulvar disease10.3DBH, DRD2, SLC6A4
45lipoadenoma10.3POMC, PRL
46fallopian tube clear cell adenocarcinoma10.3POMC, PRL
47bone fracture10.3DRD3, PRL, SLC6A3
48lymphosarcoma10.3DRD2, POMC, SLC6A4
49cold-induced sweating syndrome 210.3DRD2, POMC, PRL
50malignant peripheral nerve sheath tumor10.3OPRK1, SLC6A4

Graphical network of the top 20 diseases related to Cocaine Dependence:



Diseases related to cocaine dependence

Symptoms & Phenotypes for Cocaine Dependence

About this section

MGI Mouse Phenotypes related to Cocaine Dependence according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053759.3DBH, DRD2, DRD3, OPRM1, PDYN, POMC
2MP:00053818.9CHRNA3, DRD2, DRD3, OPRK1, OPRM1, PDYN
3MP:00053798.4DBH, DRD2, OPRK1, OPRM1, POMC, PRL
4MP:00107718.0DBH, DRD2, OPRK1, OPRM1, PDYN, POMC
5MP:00053787.8CHRNA3, DBH, DRD2, DRD3, OPRM1, PDYN
6MP:00053766.9CHRNA3, DBH, DRD2, DRD3, OPRK1, OPRM1
7MP:00036315.9CHRNA3, CHRNA5, DBH, DRD2, DRD3, OPRM1
8MP:00053865.8CHRNA3, CHRNA5, CHRNB3, DBH, DRD2, DRD3

Drugs & Therapeutics for Cocaine Dependence

About this section

Drugs for Cocaine Dependence (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 353)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DopamineapprovedPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 1375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
2
Cocaineapproved, illicitPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 150150-36-25760, 446220
Synonyms:
(-)-Cocaine
(-)-Cocaine base
(1R,2R,3S,5S)-2-(methoxycarbonyl)tropan-3-yl benzoate
(1R,2R,3S,5S)-2-Methoxycarbonyltropan-3-yl benzoate
(R)-Cocaine
(−)-cocaine
1-Cocaine
1i7z
1q72
2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)
2-beta-Carbomethoxy-3-beta-benzoxytropane
2-beta-Tropanecarboxylic acid, 3-beta-hydroxy-, methyl ester, benzoate (ester)
2beta-Carbomethoxy-3beta-benzoxytropane
3-Tropanylbenzoate-2-carboxylic acid methyl ester
3beta-Hydroxy-2beta-tropanecarboxylic acid methyl ester benzoate (ester)
50-36-2
53-21-4 (hydrochloride)
610089_ALDRICH
610089_FLUKA
AC-16037
AC-20208
AC1L1EK2
AC1L1L2T
AC1L3U2D
AC1L9JBL
Allococaine
Allopseudococaine
Badrock
Bazooka
Benzoylethylecgonine
Benzoylmethylecgonine
Bernice
Bernice [Street Name]
Bernies
Beta-Cocain
Blast
Blizzard
Blow
Blow [Street Name]
Bouncing Powder
Bump
Burese
C" Carrie
C01416
C8912_SIGMA
CHEBI:27958
CID11779748
CID2826
CID446220
CID5760
COC
CPD-9776
Cabello
Candy
Carrie
Caviar
Cecil
Cecil [Street Name]
Charlie
Chicken Scratch
Cholly
Coca
Cocain
Cocaina
Cocaine
Cocaine (TN)
Cocaine (USP)
Cocaine Free Base
Cocaine [BAN]
Cocaine free base
Cocaine solution
Cocaine-M
Cocainum
Cocktail
Coke
Cola
Corine
Crack
Crack cocaine
D-pseudococaine
D00110
DB00907
DEA No. 9041
Dama Blanca
Dama blanca
Delcaine
Depsococaine
Dextrocaine
DivK1c_000975
Dust
EINECS 200-032-7
Ecgonine methyl ester benzoate
Ecgonine methyl ester benzoate solution
Ecgonine, methyl ester, benzoate (ester)
 
Eritroxilina
Erytroxylin
Flake
Flake [Street Name]
Flex
Florida Snow
Foo Foo
Freeze
G-Rock
Girl
Girl [Street Name]
Gold Dust
Gold dust
Gold dust [Street Name]
Goofball
Green Gold
Green gold
HSDB 6469
Happy Dust
Happy Powder
Happy Trails
Happy dust
Happy dust [Street Name]
Happy powder
Happy trails
Heaven
Hell
IDI1_000975
Isocaine
Isococain
Isococaine
Jam
KBio1_000975
Kibbles N' Bits
Kibbles n' Bits
Kokain
Kokan
Kokayeen
L-Cocain
L-Cocaine
L000836
LS-157759
Lady
Lady [Street Name]
Leaf
MLS002320697
Methyl 3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
Methyl 3beta-hydroxy-1alphaH,5alphaH-tropane-2beta-carboxylate benzoate (ester)
Methyl Benzoylecgonine
Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
Methyl benzoylecgonine
MolPort-002-535-520
MolPort-003-937-722
Moonrocks
NCGC00159467-02
NINDS_000975
Neurocaine
Nose candy
Pimp's Drug
Pimp's drug
Prime Time
Pseudoallococaine
Pseudococaine
Rock
Rock [Street Name]
SMR001338843
STOCK1N-68258
Sleighride
Snort
Snow
Snow (birds)
Star Dust
Star dust
Star-Spangled Powder
Star-spangled powder
Sugar
Sweet Stuff
Toke
Toot
Toot [Street Name]
Trails
UNII-I5Y540LHVR
White girl or lady
Yeyo
Zip
[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester
beta-Cocain
cocaine
cocainum
d-Pseudococaine
l-Cocain
methyl (1S,4R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate
methyl (3S,4R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate
methyl 3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate
nchembio.284-comp4
3
Methamphetamineapproved, illicitPhase 4, Phase 3, Phase 2232537-46-210836
Synonyms:
(+ )-Methylamphetamine
(+ )-methylamphetamine
(+)-(S)-Deoxyephedrine
(+)-(S)-N-alpha-Dimethylphenethylamine
(+)-(S)-N-alpha-dimethylphenethylamine
(+)-(S)-N-α-dimethylphenethylamine
(+)-(S)-deoxyephedrine
(+)-(s)-deoxyephedrine
(+)-(s)-n-alpha-dimethylphenethylamine
(+)-2-(N-Methylamino)-1-phenylpropane
(+)-Methylamphetamine
(+)-N,alpha-Dimethyl-beta-phenylethylamine
(+)-N,alpha-Dimethylphenethylamine
(+)-N,alpha-dimethyl-beta-phenylethylamine
(+)-N,alpha-dimethylphenethylamine
(+)-N-Methylamphetamine
(+)-N-methylamphetamine
(+)-methamphetamine
(+)-methylamphetamine
(+)-n,alpha-dimethyl-beta-phenylethylamine
(+)-n,alpha-dimethylphenethylamine
(+)-n-methylamphetamine
(2S)-N-methyl-1-phenylpropan-2-amine
(AlphaS)-N,alpha-dimethylbenzeneethanamine
(S)-(+)-Deoxyephedrine
(S)-(+)-Methamphetamine
(S)-(+)-N,alpha,dimethylphenethylamine
(S)-(+)-deoxyephedrine
(S)-(+)-methamphetamine
(S)-Methamphetamine
(S)-Methylamphetamine
(S)-N,alpha-Dimethylbenzeneethanamine
(S)-N,alpha-Dimethylbenzeneethanoamine
(S)-N,alpha-dimethylbenzeneethanamine
(S)-N,alpha-dimethylbenzeneethanoamine
(S)-N,α-dimethylbenzeneethanamine
(S)-methamphetamine
(S)-methylamphetamine
(alphaS)-N,alpha-dimethylbenzeneethanamine
(s)-(+)-deoxyephedrine
(s)-(+)-methamphetamine
(s)-(+)-n,alpha,dimethylphenethylamine
(s)-methamphetamine
(s)-methylamphetamine
(s)-n,alpha-dimethylbenzeneethanamine
(s)-n,alpha-dimethylbenzeneethanoamine
(αS)-N,α-dimethylbenzeneethanamine
1-Phenyl-2-methylamino-propan
1-Phenyl-2-methylamino-propan [German]
1-Phenyl-2-methylaminopropane
139-47-9
14611-50-8
1690-86-4
2S-(+)-Methamphetamine
45952-89-4
537-46-2
AC1L1W1Z
AC1Q4SVR
B40
Benzeneethanamine, N,alpha-dimethyl-, (S)- (9CI)
Benzeneethanamine, N,alpha-dimethyl-, (alphaS)- (9CI)
C07164
C10H15N
CHEBI:6809
CHEMBL1201201
CID10836
Crank
Crank [Street Name]
Crystal Meth
Crystal Meth [Street Name]
D-(S)-Methamphetamine
D-(s)-methamphetamine
D-1-Phenyl-2-methylaminopropan
D-1-Phenyl-2-methylaminopropan [German]
D-1-Phenyl-2-methylaminopropane
D-Deoxyephedrine
D-Desoxyephedrine
D-Methamphetamine
D-Methylamphetamine
D-N,alpha-Dimethylphenethylamine
D-N,alpha-dimethylphenethylamine
D-N-Methylamphetamine
D-Phenylisopropylmethylamine
D-deoxyephedrine
D-desoxyephedrine
D-methamphetamine
D-methylamphetamine
 
D-n,alpha-dimethylphenethylamine
D-n-methylamphetamine
D-phenylisopropylmethylamine
D08187
DB01577
DEA No. 1105
Desoxyephedrine hydrochloride
Desoxyn
Desyphed
Desyphed hydrochloride
Dextromethamphetamine
EINECS 208-668-7
HSDB 3359
ICE [Street Name]
Ice
L-Methamphetamine
L-methamphetamine
LS-103331
METHAMPHETAMINE
Metamfetamina
Metamfetamina [INN-Spanish]
Metamfetamina [inn-spanish]
Metamfetamine
Metamfetamine (INN)
Metamfetamine [INN]
Metamfetamine-m
Metamfetaminum
Metamfetaminum [INN-Latin]
Metamfetaminum [Latin]
Metamfetaminum [inn-latin]
Metamphetamine
Metanfetamina
Metanfetamina [INN-Spanish]
Metanfetamina [Spanish]
Metanfetamina [inn-spanish]
Meth
Meth (Street Name)
Methamphetamine
Methamphetamine, its salts, isomers, and salts of its isomers
Methamphetaminum
Methamphetaminum [INN-Latin]
Methamphetaminum [JP]
Methamphetaminum [inn-latin]
Methyl-.beta.-phenylisopropylamine
Methyl-beta-phenylisopropylamine
Methylamphetamine
MolPort-001-794-405
Métamfétamine
N-Methyl-1-phenyl-2-propanamine
N-Methyl-beta-phenylisopropylamin
N-Methyl-beta-phenylisopropylamin [German]
N-Methyl-beta-phenylisopropylamin [german]
N-Methyl-beta-phenylisopropylamine
N-Methylamphetamine
N-methyl-beta-phenylisopropylamin [german]
N-methyl-beta-phenylisopropylamine
N-methylamphetamine
NSC 25115
NSC25115
Norodin
PDSP1_001404
PDSP1_001405
PDSP2_001388
PDSP2_001389
Phenethylamine, N,alpha-dimethyl-, (S)-(+)- (8CI)
S-(+)-Methamphetamine
S-(+)-methamphetamine
Speed
Speed [Street Name]
Stimulex
UNII-44RAL3456C
WLN: 1MY1&1R -D
d-(S)-Methamphetamine
d-1-Phenyl-2-methylaminopropan [German]
d-1-phenyl-2-methylaminopropane
d-Deoxyephedrine
d-Desoxyephedrine
d-Methamphetamine
d-Methylamphetamine
d-N,.alpha.-Dimethylphenethylamine
d-N-Methylamphetamine
d-N-methylamphetamine
d-Phenylisopropylmethylamine
d-deoxyephedrine
d-desoxyephedrine
d-phenylisopropylmethylamine
desohyephedrine
methyl-β-phenylisopropylamine
4
EthanolapprovedPhase 4, Phase 3, Phase 2, Phase 1204364-17-5702
Synonyms:
(C6-C9)Alkyl alcohol
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
1-Hydroxyethane
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
AC1L19TW
AC1Q31MM
AHD 2000
AI3-01706
ALCOHOL 5% IN D5-W
Absolute Alcohol
Absolute Ethanol
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethanol [German]
Aethylalkohol
Alcare Hand Degermer
Alcohol
Alcohol (USP)
Alcohol (ethyl)
Alcohol Anhydrous
Alcohol [USP]
Alcohol anhydrous
Alcohol dehydrated
Alcohol denatured
Alcohol etílico
Alcohol, Absolute
Alcohol, Dehydrated
Alcohol, Diluted
Alcohol, Grain
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, ethyl
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool Ethylique
Alcool Etilico
Alcool ethylique
Alcool etilico
Alcool éthylique
Algrain
Alkohol
Alkohol [German]
Alkoholu Etylowego
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C00469
C2H5OH
C2H6O
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
CHEMBL545
CID702
Caswell No. 426
Caswell No. 430
Colamine
Cologne Spirit
Cologne spirit
Cologne spirits
 
D000431
D00068
DB00898
Dehydrated Ethanol
Dehydrated alcohol
Dehydrated ethanol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured Ethanol
Denatured alcohol
Denatured ethanol
Desinfektol EL
Diluted Alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
EOH
EOX
ETA
Envision Conditioner Pdd 9020
Esumiru WK 88
EtOH
Etanolo
Etanolo [Italian]
Ethanol (9CI)
Ethanol 200 Proof
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol Vapor
Ethanol [JAN]
Ethanol solution
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl Alcohol Anhydrous
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl Hydrate
Ethyl Hydroxide
Ethyl alc
Ethyl alcohol
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl hydrate
Ethyl hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
Grain alcohol
HSDB 531
HSDB 82
HYDROXYETHYL GROUP
Hinetoless
Hydroxyethane
I14-12648
IMS 99
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated Spirit Mineralised
Methylated spirit
Methylcarbinol
MolPort-001-785-844
Molasses alcohol
NCGC00091458-01
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
SY Fresh M
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spiritus vini
Spirt
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
UNII-3K9958V90M
USAF EK-1597
Undenatured Ethanol
WLN: Q2
absolute alcohol
alcohol
alcohol etilico
bmse000297
etanol
ethanol
ethyl alcohol
grain alcohol
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
spiritus vini
Äthanol
Äthylalkohol
éthanol
5
Modafinilapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 119568693-11-84236
Synonyms:
Dea No. 1680
Modafinil
Modafinil [USAN:INN]
Modafinil [Usan:Inn]
Modafinilo
Modafinilo [Spanish]
 
Modafinilum
Modafinilum [Latin]
Moderateafinil
Modiodal
Provigil
Sparlon
modafinil
6
Naltrexoneapproved, investigational, vet_approvedPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 137816590-41-35360515
Synonyms:
16590-41-3
16676-29-2
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one
BIDD:GT0405
BPBio1_000146
BRD-K88172511-310-03-8
BRN 3596648
BSPBio_000132
C07253
CCRIS 3506
CHEBI:121459
CHEBI:7465
CHEMBL142
CID5360515
Celupan
D05113
DB00704
Depade
EINECS 240-649-9
EN-1639A
HMS2089O11
HS-0002
HSDB 6750
LS-92094
MLS002153483
MolPort-004-920-221
 
MorViva
N-Cyclopropylmethyl-14-hydroxydihydromorphinone
N-Cyclopropylmethylnoroxymorphone
Naltrexon
Naltrexona
Naltrexona [INN-Spanish]
Naltrexone
Naltrexone (USAN/INN)
Naltrexone Hcl
Naltrexone [USAN:BAN:INN]
Naltrexone [USAN:INN:BAN]
Naltrexone [Usan:Ban:Inn]
Naltrexonum
Naltrexonum [INN-Latin]
PDSP2_000847
PTI-555
Prestwick0_000116
Prestwick1_000116
Prestwick2_000116
Prestwick3_000116
ReVia
SMP1_000206
SPBio_002071
UM-792
UNII-5S6W795CQM
Vivitrex
Vivitrol
Vivitrol (TN)
naltrexone
naltrexone (ReVia)
7
Risperidoneapproved, investigationalPhase 4, Phase 2, Phase 1487106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
 
NCGC00015883-01
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
8
Heroinapproved, illicitPhase 4, Phase 3, Phase 2, Phase 1113561-27-35462328
Synonyms:
(5α,6α)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)
3,6-Diacetylmorphine
7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate
Diacetylmorphine
 
Diamorphine
O,O'-Diacetylmorphine
Smack
diacetylmorphine
diamorphine
9
Lidocaineapproved, vet_approvedPhase 4, Phase 21226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
10
Amphetamineapproved, illicitPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 1115300-62-95826, 3007
Synonyms:
(+)-.alpha.-Methylphenethylamine
(+)-.alpha.-Methylphenylethylamine
(+-)-Benzedrine
(+-)-alpha-Methylbenzeneethanamine
(+-)-alpha-Methylphenethylamine
(+-)-alpha-Methylphenylethylamine
(+/-)-Benzedrine
(+/-)-Desoxynorephedrine
(+/-)-beta-Phenylisopropylamine
(S)-(+)-.beta.-Phenylisopropylamine
(S)-.alpha.-Phenylethylamine
.alpha.-Methylbenzeneethanamine
.alpha.-Methylphenethylamine
.alpha.-Methylphenethylamine, d-form
.alpha.-Methylphenylethylamine
.beta.-Aminopropylbenzene
.beta.-Phenylisopropylamin
.beta.-Phenylisopropylamine
1-Methyl-2-phenylethylamine
1-Phenyl-2-amino-propan
1-Phenyl-2-amino-propan [German]
1-Phenyl-2-aminopropane
1-Phenyl-2-aminopropane (VAN)
1-Phenyl-2-propanamine
1-Phenyl-2-propylamine
1-Phenylpropan-2-amin
1-phenyl-2-aminopropane
1-phenylpropan-2-amine
17108-96-2
2-Amino-1-phenylpropane
3-Methoxy-a-methylbenzeneethanamine
3-Methoxyamphetamine
3-Methoxyphenylisopropylamine
3-Phenyl-2-propylamine
300-62-9
60-13-9 (sulfate (2:1))
60-15-1
610240_ALDRICH
610240_FLUKA
96332-84-2
AC1L1EYQ
AC1Q5065
AI3-02438
ALPHA-METHYL-BENZENEETHANAMIDE (SEE ALSO DL-AMPHETAMINE SULFATE)
AMPHETAMINE
AMPHETAMINE (SEE ALSO: D-AMPHETAMINE (51-64-9) & AMPHETAMINE SULFATE (60-13-9))
AMPHETAMINE, (D)
AR-1H6584
Actedron
Adderall
Adipan
Allodene
Amfetamin
Amfetamin (TN)
Amfetamina
Amfetamina [INN-Spanish]
Amfetamina [Italian]
Amfetamine
Amfetamine (INN)
Amfetamine [INN:BAN]
Amfetaminum
Amfetaminum [INN-Latin]
Amphetamin
Amphetamine
Amphetamine Sulfate
Amphetamine Sulfate (2:1)
Amphetamine resin complex
Amphetamine, its salts, optical isomers, and salts of its optical isomers
Amsustain
Anfetamina
Anfetamina [Spanish]
Anorexide
Anorexine
Benzebar
Benzedrine
Benzolone
C07514
C9H13N
CHEBI:2679
CHEMBL405
CID3007
D07445
DEA No. 1100
DL-Amphetamine solution
DL-alpha-Methylphenethylamine
Desoxyn
Desoxynorephedrin
Desoxynorephedrine
Dexampex
Dexedrine
Dextrostat
 
DivK1c_000991
Dl-1-Phenyl-2-aminopropane
Dl-Amphetamine
Dl-Benzedrine
EINECS 200-458-3
EINECS 206-096-2
Elastonon
Fenamin
Fenopromin
Fenylo-izopropylaminyl
Fenylo-izopropylaminyl [Polish]
Ferndex
Finam
HMS503G03
HSDB 3287
IDI1_000991
Isoamycin
Isoamyne
Isomyn
KBio1_000991
L-Amphetamine
L000864
LS-1148
LS-1428
Levoamphetamine
Mecodrin
Methampex
Methamphetamine HCL
MolPort-001-783-432
Mydrial
NINDS_000991
NSC 27159
NSC170999
NSC27159
NSC73713
Norephedrane
Novydrine
Oktedrin
Oprea1_447423
Ortedrine
Paredrine
Percomon
Phenamine
Phenedrine
Phenylisopropylamine
Profamina
Propisamine
Protioamphetamine
Psychedrine
Raphetamine
Rhinalator
S(+)-Amphetamine
Simpatedrin
Simpatina
Sympamin
Sympamine
Sympatedrine
Thyramine
UNII-CK833KGX7E
WLN: ZY1&1R
WLN: ZY1&1R -D
Weckamine
[1-(3-Methoxyphenyl)-2-propyl]amine
alpha-Methylbenzeneethaneamine
alpha-Methylphenethylamine
alpha-Methylphenylethylamine
amfetaminum
beta-Aminopropylbenzene
beta-Aminopropylbenzene (VAN)
beta-Phenyl-isopropylamine
beta-Phenylisopropylamin
beta-Phenylisopropylamin [German]
beta-Phenylisopropylamine
beta-phenyl-isopropylamine
component of Amodex
component of Biphetamine
d-.alpha.-Methylphenethylamine
dl-1-Phenyl-2-aminopropane
dl-Amphetamine
dl-Benzedrine
dl-alpha-Methylphenethylamine
levo-Amphetamine
m-Methoxy-a-methylphenethylamine
m-Methoxyamphetamine
nchembio.2007.55-comp27
nchembio.284-comp5
rac-(2R)-1-phenylpropan-2-amine
rac-amphetamine
racemic-Desoxynor-ephedrine
α-methylbenzeneethaneamine
α-methylphenethylamine
β-aminopropylbenzene
β-phenylisopropylamine
11
Armodafinilapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1195112111-43-0
Synonyms:
 
(–)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide
R-modafinil
12
BiperidenapprovedPhase 4, Phase 3, Phase 26514-65-82381
Synonyms:
1-(5-bicyclo[2.2.1]hept-2-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol
1-(Bicyclo(2.2.1)hept-5-en-2alpha-yl)-1-phenyl-3-piperidinopropanol
1-(bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-ol
1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol
1-Bicycloheptenyl-1-phenyl-3-piperidino-propanol-1
1-Piperidinepropanol, .alpha.-bicyclo[2.2.1]hept-5-en-2-yl-.alpha.-phenyl-, hydrochloride
1235-82-1 (hydrochloride)
3-Piperidino-1-phenyl-1-bicyclo(2.2.1)hepten-(5)-yl-propanol-(1)
3-Piperidino-1-phenyl-1-bicyclo(2.2.1)hepten-(5)-yl-propanol-(1) [German]
3-Piperidino-1-phenyl-1-bicycloheptenyl-1-propanol
5-20-02-00242 (Beilstein Handbook Reference)
514-65-8
AC1L1DJT
Akineton
Akineton (TN)
BRN 0290038
Beperiden
Biperiden (JAN/USP/INN)
Biperiden [USAN:BAN:INN:JAN]
Biperiden [USAN:INN:BAN:JAN]
Biperiden [Usan:Ban:Inn:Jan]
Biperidene
Biperidene [INN-French]
Biperidene hydrochloride
Biperideno
Biperideno [INN-Spanish]
Biperidenum
Biperidenum [INN-Latin]
 
Biperidine
C07941
CHEBI:3112
CHEMBL1101
CID2381
D00779
DB00810
EINECS 208-184-6
HMS2093N17
HSDB 7639
KL 373
L001222
LS-116068
MolPort-003-666-707
NCGC00182965-02
NCIOpen2_009564
PDSP1_000821
PDSP2_000808
Prestwick0_000502
Prestwick1_000502
Prestwick2_000502
SPBio_002344
UNII-0FRP6G56LD
alpha-(Bicyclo(2.2.1)hept-5-en-2-yl)-alpha-phenyl-1-piperidino propanol
alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol
alpha-Bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
alpha-bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
biperiden
13
OndansetronapprovedPhase 4, Phase 230999614-02-54595
Synonyms:
(RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one
1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one
103639-04-9 (mono-hydrochloride dihydrate)
108303-49-7
116002-70-1
9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one
9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one
9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
99614-01-4 (mono-hydrochloride)
99614-02-5
AB00373674
AC1L1IIM
AKOS000599484
Apo-ondansetron
BAS 00717177
BPBio1_001118
BRD-A19736161-001-01-8
BRD-A19736161-003-03-0
BRN 3622981
BSPBio_001016
C07325
C18H19N3O
CBDivE_008994
CHEMBL46
CID4595
CPD001307702
D00456
DB00904
DESMETHYLONDANSETRON
GR 38032
GR 38032X
GR-38032F
GR38032F
HMS2090H16
I06-0687
I06-1329
 
L000456
LS-172305
LS-51878
MolPort-001-944-253
NCI60_022780
Novo-ondansetron
Ondansetron
Ondansetron (JAN/USP/INN)
Ondansetron [USAN:INN:BAN]
Ondansetron, (+,-)-Isomer
Oprea1_435466
Oprea1_852372
PHL-ondansetron
PMS-ondansetron
Prestwick0_001058
Prestwick1_001058
Prestwick2_001058
Prestwick3_001058
Ratio-ondansetron
SAM002589958
SN-307
SPBio_002938
STK370548
STOCK4S-10990
Sandoz ondansetron
TL8006071
TimTec1_001750
UNII-4AF302ESOS
ZOFRAN IN PLASTIC CONTAINER
Zofran
Zofran ODT
Zofran ODT (TN)
Zofran odt
Zophren
Zudan
ondansetron
ondansetron (Zofran)
14
MethadoneapprovedPhase 4, Phase 2, Phase 3, Phase 131976-99-34095
Synonyms:
(+)-Methadone
(+-)-Methadone
(+/-)-Methadone
(+/-)-Methadone hydrochloride
(+/-)-Tussal
(-)-(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(-)-Methadone
(6R)-Methadone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-hetpanone
(S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(±)-methadone
1095-90-5 (hydrochloride)
297-88-1
3-14-00-00278 (Beilstein Handbook Reference)
3-14-00-00279 (Beilstein Handbook Reference)
3-Hetpanone, 6-(dimethylamino)-4,4-diphenyl-, (R)- (9CI)
5653-80-5
6-(Dimethylamino)-4,4-diphenyl-3-heptanone dl-mixture
6-(dimethylamino)-4,4-diphenylheptan-3-one
6-Dimethylamino-4,4-diphenyl-3-heptanone
6-dimethylamino-4,4-di(phenyl)heptan-3-one
6S-Methadone
76-99-3
A 4624
AC-16055
AC1L1HEG
AC1Q2RLW
AN 148
AN-148 (*Hydrochloride*)
Adanon
Adanon hydrochloride
Adolan
Algidon
Algolysin
Algovetin
Althose
Althose hydrochloride
Amidon
Amidone
BRN 3213667
BRN 3213668
BRN 3213669
Biscuits
Butalgin
C07163
CHEBI:6807
CHEMBL651
CID4095
D08195
DB00333
DEA No. 9250
DL-Methadone hydrochloride
Depridol
Dextromethadone
Diaminon
Diaminon hydrochloride
DivK1c_000963
Dl-Methadone
Dollies
Dolly
Dolofin hydrochloride
Dolohepton
Dolophin
Dolophin hydrochloride
Dolophine
Dolophine (*Hydrochloride*)
Dolophine HCL
EINECS 200-996-9
Fenadon
Fenadone
 
Fenadone (*Hydrochloride*)
HSDB 3119
Heptadon
Heptadone
Heptadone (*Hydrochloride*)
Heptanon
Heptanon (*Hydrochloride*)
Heptanon (pharmaceutical)
Hoechst 10820
Hoescht 10820 (*Hydrochloride*)
IDI1_000963
K 174
KBio1_000963
Ketalgin
Ketalgin hydrochloride
L-(+)-Methadone
L-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
L-Polamidon
L000874
LS-74485
LS-74486
LS-74487
Levometadona
Levometadona [INN-Spanish]
Levomethadone [INN]
Levomethadonum
Levomethadonum [INN-Latin]
Levothyl
Mecodin
Mephenon
Metadona
Metadona [INN-Spanish]
Metadona [Spanish]
Metadone
Metadone [DCIT]
Metasedin
Methadon
Methadona
Methadona [Spanish]
Methadone (BAN)
Methadone HCL
Methadone HCL Intensol
Methadone M
Methadone [INN:BAN]
Methadone hydrochloride
Methadonum
Methadonum [INN-Latin]
Methadonum [Latin]
Methadose
Methaquaione
Miadone
Moheptan
MolPort-001-785-650
NINDS_000963
Phenadone
Phenadone (*Hydrochloride*)
Phenadone hydrochloride
Physeptone
Polamidon
Polamidone
Polamivet
Racemic methadone
S-(+)-Methadone
Sedo-Rapide
Tussol
UNII-UC6VBE7V1Z
Westadone
d-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
d-Methadone
dl-Methadone
l-Methadone
l-Polamivet
methadone
15
BupropionapprovedPhase 4, Phase 3, Phase 2, Early Phase 131934841-39-9, 34911-55-2444
Synonyms:
( -)-2-(tert-Butylamino)-3'-chloropropiophenone
( -)-2-(tert-Butylamino)-3'-chlorpropiophenon
(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-Bupropion
.alpha.-(tert-Butylamino)-m-chloropropiophenone
1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one
2-(Tert-Butylamino)-3'-chloropropiophenone
2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one
34841-36-6 (hydrochloride)
34841-39-9
34911-55-2
AB00053756
AC-197
AC1L198Y
AMFEBUTAMONE HCl
Amfebutamon
Amfebutamona
Amfebutamona [INN-Spanish]
Amfebutamone
Amfebutamonum
Amfebutamonum [INN-Latin]
BPBio1_000042
BRD-A05186015-003-05-7
BRN 2101062
BSPBio_000038
BSPBio_002247
Bupropion (INN)
Bupropion (Old RN)
Bupropion (USAN)
Bupropion Hcl
Bupropion SR
Bupropion [INN:BAN]
Bupropion hydrocloride
C06860
CHEBI:3219
CHEMBL894
CID444
CPD000472526
D07591
DB01156
DivK1c_007050
Elont
 
HMS2051G10
HMS2089G14
Jsp006301
KBio1_001994
KBio2_002143
KBio2_004711
KBio2_007279
KBio3_001467
KBioGR_001168
KBioSS_002143
L000725
LS-122817
Lopac0_000166
MLS001424015
MolPort-003-845-432
NCGC00015122-06
NCGC00089751-02
NCI60_002714
NSC315851
Prestwick0_000249
Prestwick1_000249
Prestwick2_000249
Prestwick3_000249
SAM001246699
SMR000472526
SPBio_001817
SPBio_002257
SpecPlus_000954
Spectrum2_001659
Spectrum3_000644
Spectrum4_000614
Spectrum5_001406
Spectrum_001663
TL8002604
UNII-01ZG3TPX31
Wellbatrin
Wellbutrin
Wellbutrin SR
Wellbutrin XL
Zyban
alpha-(tert-butylamino)-m-chloropropiophenone
amfebutamonum
bupropion
16
NicotineapprovedPhase 4, Phase 3, Phase 1, Phase 2105054-11-5942, 89594
Synonyms:
(−
(+)-Nicotine
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(-)-Nicotine
(-)-Nicotine solution
(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE
(S)-(-)-Nicotine
(S)-(−)-nicotine
(S)-3-(1-methylpyrrolidin-2-yl)pyridine
(S)-3-(N-methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
(−)-nicotine
)-1-Methyl-2-(3-pyridyl)pyrrolidine
)-Nicotine
)-Nicotine solution
1-Methyl-2-(3-pyridal)-Pyrrolidine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
1uw6
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-Pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-(N-methylpyrollidino)pyridine
3-N-Methylpyrrolidine
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine
36733_FLUKA
36733_RIEDEL
434F7990-3240-4A43-ACEC-E6CC1E495FA0
46343_FLUKA
46343_RIEDEL
54-11-5
AC1L3I79
AC1Q3ZOC
AI3-03424
BB_NC-0777
BIDD:GT0599
BRD-K05395900-322-02-1
Black Leaf
Black Leaf 40
C00745
CCRIS 1637
CHEBI:17688
CHEMBL3
CID89594
CPD000059074
Campbell's Nico-Soap
Caswell No. 597
Commit
D-Nicotine
D03365
DL-tetrahydronicotyrine
Destruxol
Destruxol Orchid Spray
EINECS 200-193-3
ENT 3,424
EPA Pesticide Chemical Code 056702
Emo-Nik
Flux Maag
Fumeto bac
Fumetobac
HSDB 1107
Habitrol
Habitrol (TN)
L(-)-nicotine
L(−)-nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
 
L-Nicotine
LS-202
MLS001055457
MLS001335905
Mach-Nic
Methyl-2-pyrrolidinyl)pyridine
Micotine
MolPort-000-744-731
N3876_SIGMA
N5511_FLUKA
N5511_SIGMA
NCGC00090693-01
NCGC00090693-02
NCGC00090693-03
NCGC00090693-04
NCGC00090693-05
NCGC00090693-06
NCGC00090693-07
NCT
NICOTINE AND SALTS
NSC 5065
NSC97238
Niagara P.A. Dust
Nic-Sal
Nico-Dust
Nico-Fume
Nicocide
Nicoderm
Nicoderm Cq
Nicoderm Patch
Nicorette
Nicorette Plus
Nicotin
Nicotina
Nicotina [Italian]
Nicotine
Nicotine (USP)
Nicotine (compounds related to)
Nicotine Alkaloid
Nicotine Patch
Nicotine Polacrilex
Nicotine [BSI:ISO]
Nicotine [UN1654]
Nicotine [UN1654] [Poison]
Nicotine [USAN]
Nicotrol
Nicotrol Inhaler
Nicotrol Ns
Nictoine patch
Nikotin
Nikotin [German]
Nikotyna
Nikotyna [Polish]
Ortho N-4 Dust
Ortho N-5 Dust
PDSP1_000113
PDSP1_000465
PDSP2_000463
PDSP2_000555
Prostep
R)-(+)-Nicotine
RCRA waste no. P075
RCRA waste number P075
SAM002564224
SDCCGMLS-0066911.P001
SMR000059074
Tendust
Transdermal Nicotine
UN1654
a -N-Methylpyrrolidine
a-N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methyl pyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
bmse000105
delta-Nicotine
nicotine
nicotine replacement patch
17
Lamotrigineapproved, investigationalPhase 4, Phase 3, Phase 218384057-84-13878
Synonyms:
3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine
3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine
6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
84057-84-1
AC-10298
AC1L1GWT
BIDD:GT0794
BW 430C
BW-430C
Bio-0056
C047781
CHEBI:138727
CHEBI:6367
CHEMBL741
CID3878
CPD000058464
Crisomet
D00354
DB00555
Desitin Brand of Lamotrigine
EINECS 281-901-8
EU-0100688
EUR-1048
Faes Brand of Lamotrigine
GI 267119X
GW 273293
Glaxo Wellcome Brand of Lamotrigine
GlaxoSmithKline Brand of Lamotrigine
HMS2051C10
HMS2089M08
HMS2093P21
HSDB 7526
Juste Brand of Lamotrigine
L 3791
L3791_SIGMA
LS-155249
 
Labileno
Lamictal
Lamictal (TN)
Lamictal CD
Lamictal Cd
Lamictal ODT
Lamictal XR
Lamictin
Lamiktal
Lamitor
Lamotrigina
Lamotrigina [Spanish]
Lamotrigine
Lamotrigine (JAN/USAN/INN)
Lamotrigine [USAN:INN:BAN]
Lamotriginum
Lamotriginum [Latin]
Lopac-L-3791
Lopac0_000688
MLS000069685
MLS000759486
MLS001077325
MolPort-003-666-744
NCGC00015605-01
NCGC00015605-02
NCGC00015605-06
NCGC00015605-08
NCGC00022936-02
NCGC00022936-04
NCGC00022936-05
NSC746307
SAM001246697
SMP2_000303
SMR000058464
STK628377
Tocris-1611
UNII-U3H27498KS
ZINC00013156
lamotrigine
18
Naloxoneapproved, vet_approvedPhase 4, Phase 2, Phase 3, Phase 1243465-65-65284596
Synonyms:
(-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one
(-)-Naloxone
(5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one
(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one
1-N-Allyl-14-hydroxynordihydromorphinone
1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone
12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone
12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one
17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one
17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one
17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one
3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one
357-08-4 (hydrochloride)
465-65-6
BIDD:GT0110
BPBio1_000136
BRD-K67511046-003-03-7
BRN 1089071
BSPBio_000122
C07252
CHEBI:7459
CHEMBL80
CID5284596
D08249
DB01183
DBL Naloxone
DBL Naloxone (TN)
EINECS 207-365-7
EN 1530 Base
EN 1530 base
HMS2090F20
HSDB 3279
L-Naloxone
LS-187184
LS-92141
 
MolPort-002-536-640
Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy- (8CI)
Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- (9CI)
N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon
N-Allyl-noroxymorphone
N-Allylnoroxymorphone
NCGC00024674-02
NSC 70413
NSC70413
Nalone
Nalossone
Nalossone [DCIT]
Nalossone [Dcit]
Naloxona
Naloxona [INN-Spanish]
Naloxone
Naloxone (INN)
Naloxone HCl
Naloxone [INN:BAN]
Naloxonum
Naloxonum [INN-Latin]
Narcan
Narcanti
Narcon
PDSP2_001520
Prestwick0_000111
Prestwick1_000111
Prestwick2_000111
Prestwick3_000111
SMP1_000205
SPBio_002061
STOCK1N-69923
UNII-36B82AMQ7N
l-N-Allyl-14-hydroxynordihydromorphinone
l-N-Allyl-7,8-dihydro-14-hydroxynormorphinone
l-Naloxone
n-Allylnoroxymorphone
naloxone
19
Carbamazepineapproved, investigationalPhase 4, Phase 2131298-46-42554
Synonyms:
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
298-46-4
5-Carbamoyl-5H-dibenz(b,f)azepine
5-Carbamoyl-5H-dibenz[b,F]azepine
5-Carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenzo(b,F)azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
5-Carbamoyldibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,F)azepine
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamyldibenzo(b,f)azepine
5H-Dibenz(b,F)azepine-5-carboxamide
5H-Dibenz(b,f)azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5- carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
5H-Dibenzo[b,f]azepine-5-carboxamide
85756-57-6 (di-hydrate)
AC-10560
AC1L1DXT
AC1Q4ZSU
AC1Q4ZSV
AKOS003235644
Amizepin
Amizepine
Apo-Carbamazepine
Atretol
BIDD:GT0479
BIM-0050280.0001
BPBio1_000225
BRD-K71799949-001-06-7
BRN 1246090
BSPBio_000203
BSPBio_001929
Bio-0751
Bipotrol
Biston
C 4024
C06868
C4024_SIAL
C4024_SIGMA
C8981_SIAL
CARBAMAZEPINE, U.S.P.
CAS-298-46-4
CBChromo1_000350
CBZ
CDS1_002710
CHEBI:3387
CHEMBL108
CID2554
CPD001227191
Calepsin
Carbamazepan
Carbamazepen
Carbamazepin
Carbamazepina
Carbamazepina [INN-Spanish]
Carbamazepine (JP15/USP/INN)
Carbamazepine [USAN:INN:BAN:JAN]
Carbamazepinum
Carbamazepinum [INN-Latin]
Carbamazépine
Carbamezepine
Carbatrol
Carbatrol extended-release
Carbazepin
Carbazepine
Carbelan
ChemDiv1_018966
D00252
DB00564
DivK1c_000388
DivK1c_003750
EINECS 206-062-7
EU-0100292
Epitol
Epitol, Equetro, Tegretol, Biston, Calepsin, Carbamazepine
Equetro
Equetro (TN)
Finlepsin
G 32883
G-32883
Geigy 32883
HMS1568K05
 
HMS1920I17
HMS2090M07
HMS2091O19
HMS501D10
HMS640O02
HSDB 3019
I06-0863
IDI1_000388
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
KBioGR_000724
KBioSS_000516
Karbamazepin
LS-60362
Lexin
Lopac-C-4024
Lopac0_000292
MLS000069652
MLS001055475
MLS001074172
MolPort-000-710-574
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-07
NCGC00015234-13
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
NINDS_000388
NSC 169864
NSC169864
Neurotol
Neurotop retard
Novo-Carbamaz
Nu-Carbamazepine
Oprea1_790775
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
Prestwick_104
S1693_Selleck
SAM002264603
SMR000058201
SMR001227191
SPBio_000170
SPBio_002124
SPD-417
SPECTRUM1500159
STK177357
Sirtal
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
Spectrum_000096
Stazepin
Stazepine
Taro-Carbamazepine
Taro-Carbamazepine Cr
Tegretal
Tegretol
Tegretol (TN)
Tegretol Chewtabs
Tegretol Cr
Tegretol-Xr
Telesmin
Teril
Timonil
Trimonil
UNII-33CM23913M
WLN: T C676 BNJ BVZ
ZINC00004785
benzo[b][1]benzazepine-11-carboxamide
carbamazepine
carbamazepine (Tegretol)
nchem.859-comp7
20
Buprenorphineapproved, illicit, investigational, vet_approvedPhase 4, Phase 2, Phase 3, Phase 139752485-79-740400, 644073
Synonyms:
(-)-Buprenorphine
(-)-buprenorphine
(5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-6-(methyloxy)-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol
(5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol
(−)-buprenorphine
17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl-6-methoxy-6,14-endo-ethanomorphinan-3-ol
17-cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol
2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-7alpha-yl)-3,3-dimethyl-2-butanol
2-(N-cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol
2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol
21-(Cyclopropyl-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-cyclopropyl-7alpha-(2-hydroxy-3,3-dimethyl-2-butyl)-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine
52485-79-7
53152-21-9 (hydrochloride)
6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-,
6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (alphaS,5alpha,7alpha)- (9CI)
6029-M
AC1L23NL
AC1L9B1M
AC1LD8IH
Buprel
Buprenex
Buprenophine
Buprenorfina
Buprenorfina [INN-Spanish]
 
Buprenorphine (JAN/INN)
Buprenorphine Hcl
Buprenorphine [INN:BAN]
Buprenorphinum
Buprenorphinum [INN-Latin]
C08007
C29H41NO4
CHEBI:3216
CHEMBL1201894
CHEMBL47085
CID40400
CID441363
CID5311033
CID6321408
CID644073
D07132
DB00921
DEA No. 9064
EINECS 257-950-6
LS-67682
MolPort-004-285-844
PDSP2_000111
Probuphine
RX 6029M
RX-6029-M
Subutex
Temgesic
Temgesic (TN)
UNII-40D3SCR4GZ
[5alpha,7alpha(S)]-17-(Cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol
buprenorphine
21
Oxytocinapproved, vet_approvedPhase 4, Phase 2, Phase 340850-56-6439302, 53477758
Synonyms:
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
(Arg8)-Vasopressin
(Arg8)-Vasotocin
1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
50-56-6
AC1L9735
Argipressin
Argpressin Acetate
BCBcMAP01_000094
Biotinyl-(Arg8)-Vasopressin
C00746
CHEBI:492195
CHEBI:7872
CHEMBL395429
CID439302
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
D00089
Disulfide bridge Cys1-Cys6
Gly-Leu-Pro-c
HS-2021
 
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide
MolPort-003-938-941
NCGC00167132-01
O3251_SIGMA
O4375_SIGMA
OXT
OXYTOCIN
Ocytocin
Oxitocina
Oxytocic hormone
Oxytocin (JP15/USP/INN)
Oxytocin (TN)
Oxytocin 10 Usp Units In Dextrose 5%
Oxytocin 20 Usp Units In Dextrose 5%
Oxytocin 5 Usp Units In Dextrose 5%
Oxytocin Acetate
Oxytocin injection
Oxytocine
Oxytocinum
Pitocin
Pitocin (TN)
Syntocinon
Syntocinon (TN)
TI-001
alpha-Hypophamine
nchembio.184-comp2
22
AcetylcysteineapprovedPhase 4, Phase 2, Phase 1, Early Phase 1316616-91-112035
Synonyms:
(2R)-2-acetylamino-3-Sulfanylpropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoic acid
(R)-Mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
 
Fluprowit
L-Acetylcysteine
L-alpha-acetamido-beta-Mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-ACETYL-L-cysteine
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
23
DisulfiramapprovedPhase 4, Phase 2, Phase 13597-77-83117
Synonyms:
1,1'-dithiobis(N,N-diethylthioformamide)
11078-22-1
155-01-1
86720_ALDRICH
86720_FLUKA
97-77-8
AB00051976
AC1L1F7H
AC1Q2YXI
AI3-27340
AKOS000120201
ARONIS24121
Abstenisil
Abstensil
Abstinil
Abstinyl
Accel TET
Accel TET-R
Accel Tet
Accel Tet-R
Akrochem TETD
Akrochem Tetd
Alcophobin
Alk-Aubs
Alk-aubs
Ancazide ET
Ancazide Et
Antab use
Antabus
Antabuse
Antabuse (TN)
Antabuse (tn)
Antadix
Antaenyl
Antaethan
Antaethyl
Antaetil
Antalcol
Antetan
Antethyl
Antetil
Anteyl
Anthethyl
Anti-Ethyl
Anti-ethyl
Antiaethan
Anticol
Antietanol
Antiethanol
Antietil
Antikol
Antivitium
Antivitium (Spain)
Aversan
Averzan
B0479
BPBio1_000060
BSPBio_000054
BSPBio_001930
Bis(diethylthiocarbamoyl) disulfide
Bonibal
C01692
C10H20N2S4
CAS-97-77-8
CCRIS 582
CHEBI:4659
CHEMBL964
CID3117
CPD000059171
Contralin
Contrapot
Cronetal
D00131
D004221
DB00822
Dicupral
Disetil
Disulfan
Disulfiram
Disulfirame
Disulfirame [DCIT]
Disulfiramo
Disulfiramum
Disulfirm
Disulfram
Disulfuram
Disulphuram
Dupon 4472
Dupont Fungicide 4472
EINECS 202-607-8
ENT 27,340
EU-0101164
Ekagom DTET
Ekagom Dtet
Ekagom TEDS
Ekagom TETDS
Ekagom Teds
Ekagom Tetds
Ekaland TETD
Ekaland Tetd
Ephorran
Espenal
Esperal
Esperal [France]
Eta bus
Etabus
Ethyl Thiram
Ethyl Thiudad
Ethyl Thiurad
Ethyl Tuads
Ethyl Tuads Rodform
Ethyl Tuex
Ethyl tuads
Ethyldithiourame
Ethyldithiurame
Etyl Tuex
Exhoran
Exhorran
Gababentin
HMS1568C16
HMS1920I16
HMS2051M17
 
HMS2090C18
HMS2091O22
HSDB 3317
Hoca
KBio2_001490
KBio2_004058
KBio2_006626
KBio3_001150
KBioGR_000895
KBioSS_001490
Krotenal
LS-2031
Lopac-T-1132
Lopac0_001164
MLS000069818
MLS000758264
MLS001076475
MolPort-001-792-519
N,N,N',N'-tetraethylthiuram disulfide
NCGC00016000-01
NCGC00016000-02
NCGC00016000-03
NCGC00016000-09
NCGC00094423-01
NCGC00094423-02
NCGC00094423-03
NCGC00094423-05
NCGC00094423-06
NCGC00094423-07
NCI-C02959
NSC 190940
NSC 25953
NSC-25953
NSC25953
Nocbin
Nocceler
Nocceler TET
Nocceler TET-G
Nocceler Tet
Nocceler Tet-G
Noxal
Noxal (VAN)
Perkacit TETD
Perkacit Tetd
Perkait TETD
Perkait Tetd
Prestwick0_000097
Prestwick1_000097
Prestwick2_000097
Prestwick3_000097
Prestwick_182
Refusal
Ro-Sulfiram
Ro-Sulfram-500 (USA)
Ro-sulfiram
Robac TET
S00294
S1680_Selleck
SAM001247028
SBB058706
SMR000059171
SPBio_001191
SPBio_001993
SPECTRUM1500262
STL069539
Sanceler TET
Sanceler TET-G
Sanceler Tet
Sanceler Tet-G
Soxinol TET
Soxinol Tet
Spectrum2_001176
Spectrum3_000405
Spectrum4_000228
Spectrum5_001590
Spectrum_001010
Stopaethyl
Stopethyl
Stopety
Stopetyl
Super Rodiatox
T 1132
T1132_SIGMA
TATD
TETD
THIOCID
TTD
TTS
TTS X
TTS x
Tenurid
Tenutex
Tetidis
Tetradin
Tetradine
Tetraethylthioperoxydicarbonic Diamide
Tetraethylthiram Disulfide
Tetraethylthiram Disulphide
Tetraethylthiuram
Tetraethylthiuram Disulfide
Tetraethylthiuram Disulphide
Tetraethylthiuram Sulfide
Tetraethylthiuran Disulfide
Tetraetil
Teturam
Teturamin
Thiocid
Thiophos
Thioscabin
Thireranide
Thiuram E
Thiuranide
Tillram
Tiuram
Tuads, ethyl
UNII-TR3MLJ1UAI
UPCMLD-DP090
UPCMLD-DP090:001
Usaf B-33
WLN: 2N2 & YUS & S 2
ZINC01529266
disulfiram
nchembio.559-comp2
tet raethylthiuram
24
Azacitidineapproved, investigationalPhase 4506320-67-29444
Synonyms:
2-(beta-D-Ribofuranosyl)-4-amino-1,3,5-triazin-2-one
320-67-2
4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one
4-Amino-1-beta-D-ribofuranosyl-1,3,5-traizin-2(1H)-one
4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one
4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one
4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one
4-Amino-1-beta-d-ribofuranosyl-1,3,5-triazin-2(1H)-one
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triaz
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one
4-amino-1-beta-L-ribofuranosyl-1,3,5-triazin-2(1H)-one
5 AZC
5 Azacytidine
5-AC
5-AZAC
5-AZCR
5-Azacytidine
5-aza-CR
5-azacitidine
5-azacytidine
5-azacytidine, Mylosar, Ladakamycin, Vidaza, Azacitidine
5AzaC
A 2385
A1287_SIGMA
A2385_SIGMA
AC1L1T1Y
Antibiotic U 18496
Azacitidina
Azacitidina [INN-Spanish]
Azacitidine
Azacitidine (JAN/USAN/INN)
Azacitidine [USAN:INN]
Azacitidinum
Azacitidinum [INN-Latin]
Azacytidine
BCBcMAP01_000083
BRN 0620461
BSPBio_003157
C11262
CCRIS 60
CHEBI:2038
CHEMBL1489
CID9444
CPD000857239
D001374
D03021
DB00928
DivK1c_000125
EINECS 206-280-2
EU-0100035
FT-0081170
HMS1921J22
HMS2092D08
HMS500G07
HSDB 6879
IDI1_000125
InChI=1/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
 
Jsp005945
KBio1_000125
KBio2_001742
KBio2_002556
KBio2_004310
KBio2_005124
KBio2_006878
KBio2_007692
KBio3_002657
KBio3_003034
KBioGR_001444
KBioGR_002556
KBioSS_001742
KBioSS_002565
LS-1189
Ladakamycin
Lopac0_000035
MLS001333121
MLS001333122
MLS002153249
MolMap_000062
Mylosar
NCGC00090851-01
NCGC00090851-02
NCGC00090851-03
NCGC00090851-04
NCGC00090851-08
NCGC00178234-01
NCI-C01569
NINDS_000125
NS-17
NSC 102816
NSC-102816
NSC102816
Pharmion Brand of Azacitidine
S1782_Selleck
SAM002264595
SMR000857239
SPBio_000892
SPECTRUM1502111
ST056940
Spectrum2_000786
Spectrum3_001509
Spectrum4_000922
Spectrum5_001166
Spectrum_001262
TL80073599
U 18496
U-18496
UNII-M801H13NRU
Vidaza
Vidaza (TN)
WR-183027
ZINC03861768
cMAP_000082
mylo sar
pyrimidine antimetabolite: inhibits nucleic acid replication
s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl- (8CI)
wr 183027
25
Caffeineapproved, NutraceuticalPhase 4, Phase 2, Phase 3, Phase 138058-08-22519
Synonyms:
07E4FB58-FD79-4175-8E3D-05BF96954522
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-Trimethylxanthine
1,3,7-trimethyl-2,6-dioxopurine
1,3,7-trimethylpurine-2,6-dione
1,3,7-trimethylxanthine
1-3-7-TRIMETHYLXANTHINE
1-Methyl-Theobromine
1-methyltheobromine
137X
1gfz
1l5q
1l7x
27602_FLUKA
2a3b
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
3,7-dihydro-1,3,7-trimethyl-1H-purine
5-26-13-00558 (Beilstein)
58-08-2
7-Methyl Theophylline
7-Methyltheophylline
7-methyltheophylline
71701-02-5
75035_FLUKA
95789-13-2
A.S.A. and Codeine Compound
AC-12774
AC1L1DV2
AC1Q3Z23
ACon1_000085
AI3-20154
AKOS000121334
Alert-Pep
Alert-pep
Anacin Maximum Strength
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anhydrous caffeine (TN)
Anoquan
BIDD:ER0554
BIDD:GT0632
BIDD:PXR0172
BIM-0050216.0001
BRD-K02404261-001-02-7
BRD-K02404261-001-03-5
BRN 0017705
BSPBio_001921
Berlin-Chemie Brand of Caffeine
Bio-0579
Bio1_000473
Bio1_000962
Bio1_001451
Bristol-Myers Squibb Brand of Caffeine
C 0750
C07481
C0750_SIAL
C1778_SIAL
C2042
C6035_FLUKA
C6035_SIGMA
C7731_SIAL
C8960_SIAL
CCRIS 1314
CFF
CHEBI:27732
CHEMBL113
CID2519
CU-01000012617-3
Cafamil
Cafcit
Cafecon
Cafeina
Cafergot
Cafeína
Caffedrine
Caffedrine Caplets
Caffein
Caffeina
Caffeina [Italian]
Caffeine (USP)
Caffeine (natural)
Caffeine Pure
Caffeine [BAN:JAN]
Caffeine solution
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeine, anhydrous
Caffeine, synthetic
Caffeinum
Caffine
Cafipel
Caféine
Coffein
Coffein [German]
Coffeine
Coffeinum
Coffeinum N
Coffeinum Purrum
Compound 65
D002110
D00528
DB00201
DHC Plus
DHCplus
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
DivK1c_000730
Durvitan
EINECS 200-362-1
EU-0100228
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA No. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline Brand of Caffeine
Guaranine
HMS1920I09
HMS2091O11
HMS502E12
HSDB 36
Hycomine
Hycomine Compound
I14-4386
 
IDI1_000730
Invagesic
Invagesic Forte
KBio1_000730
KBio2_001781
KBio2_004349
KBio2_006917
KBio3_001141
KBioGR_002325
KBioSS_001781
Keep Alert
Kofein
Kofein [Czech]
Koffein
Koffein [German]
L000155
LS-237
Lanorinal
Lopac-C-0750
Lopac0_000228
MEGxp0_001350
MLS001055341
MLS001056714
MLS001066409
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura Brand of Caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Midol Maximum Strength
Migergot
Miudol
MolMap_000054
MolPort-000-730-850
Monohydrate Caffeine
Monomethyl Derivative of Theophylline
Monomethyl derivative of Theophylline
NCGC00015208-01
NCGC00015208-02
NCGC00015208-04
NCGC00015208-14
NCGC00090699-01
NCGC00090699-02
NCGC00090699-03
NCGC00090699-04
NCGC00090699-05
NCGC00090699-06
NCGC00090699-07
NCGC00090699-08
NCGC00090699-09
NCGC00168808-01
NCGC00168808-02
NCI-C02733
NCIOpen2_008255
NINDS_000730
NSC 5036
NSC5036
Natural Caffeinum
Nix Nap
No Doz
No-Doz
Nodaca
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
Organex
Orphengesic
Orphengesic Forte
P-A-C Analgesic Tablets
PDSP1_001016
PDSP1_001235
PDSP2_001000
PDSP2_001219
Passauer Brand of Caffeine
Pep-Back
Percoffedrinol N
Percutafeine
Phensal
Pierre Fabre Brand of Caffeine
Probes1_000150
Probes2_000128
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick Pep
Quick-Pep
Refresh'n
Republic Drug Brand of Caffeine
SDCCGMLS-0064595.P001
SDCCGMLS-0064595.P002
SK 65 Compound
SK-65 Compound
SMR000326667
SPBio_001222
SPECTRUM1500155
STK177283
Seid Brand of Caffeine
Spectrum2_001261
Spectrum3_000321
Spectrum4_001782
Spectrum5_000423
Spectrum_001301
Stim
Synalgos-Dc
TNP00310
Thein
Theine
Theobromine ME
Theobromine Me
Theophylline ME
Theophylline Me
Theophylline, 7-methyl
Thompson Brand 1 of Caffeine
Thompson Brand 2 of Caffeine
Tirend
Tri-Aqua
Triad
UNII-3G6A5W338E
Ultra Pep-Back
Vivarin
W222402_ALDRICH
WLN: T56 BN DN FNVNVJ B1 F1 H1
Wake-Up
Wigraine
Xanthine, 1,3,7-trimethyl
ZINC00001084
bmse000206
cafeine
caffeine
caffenium
component of Cafergot
nchembio.243-comp7
nchembio.63-comp5
nchembio774-comp2
teina
teína
26
Cholineapproved, nutraceuticalPhase 4, Phase 314862-49-7305
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(beta-hydroxyethyl)trimethylammonium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
2-Hydroxy-N,N,N-trimethylethanaminium
Bilineurine
Biocolina
Biocoline
Choline
Choline cation
 
Choline ion
Cholinum
Hepacholine
Hormocline
Lipotril
N,N,N-Trimethylethanol-ammonium
N,N,N-Trimethylethanolammonium
N,N,N-trimethylethanol-ammonium
N-trimethylethanolamine
Neocolina
Paresan
trimethylethanolamine
27Nootropic AgentsPhase 4, Phase 3, Phase 2701
28AnestheticsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 19001
29Cytochrome P-450 CYP3A InducersPhase 4, Phase 3, Phase 2, Phase 11101
30Dopamine agonistsPhase 4, Phase 2, Phase 3, Phase 1618
31AnticonvulsantsPhase 4, Phase 3, Phase 2, Phase 12620
32Adrenergic AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 15140
33Protective AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 17190
34NarcoticsPhase 4, Phase 3, Phase 2, Phase 13486
35Narcotic AntagonistsPhase 4, Phase 3, Phase 2, Phase 1906
36Analgesics, OpioidPhase 4, Phase 2, Phase 3, Phase 13091
37Antidepressive Agents, Second-GenerationPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 11287
38Antidepressive AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 12666
39Wakefulness-Promoting AgentsPhase 4, Phase 3, Phase 2, Phase 1192
40Dopamine AntagonistsPhase 4, Phase 2, Phase 1, Early Phase 11083
41Respiratory System AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 14818
42AnalgesicsPhase 4, Phase 2, Phase 3, Phase 111287
43Phosphodiesterase InhibitorsPhase 4, Phase 2, Phase 3, Phase 11254
44ParasympatholyticsPhase 4, Phase 3, Phase 2, Phase 11050
45Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 13464
46Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 117734
47Purinergic P1 Receptor AntagonistsPhase 4, Phase 2, Phase 3, Phase 1348
48Vasoconstrictor AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 12027
49AntipruriticsPhase 4, Phase 2864
50AntiemeticsPhase 4, Phase 2, Phase 13888

Interventional clinical trials:

(show top 50)    (show all 406)
idNameStatusNCT IDPhase
1Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine DependenceUnknown statusNCT00495183Phase 4
2Pharmacologic MRI in Cocaine AddictionUnknown statusNCT01652378Phase 4
3Cognitive Correlates of Substance Abuse - 11Unknown statusNCT00000346Phase 4
4Citicoline for Bipolar 1 Disorder and Cocaine DependenceCompletedNCT00619723Phase 4
5An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine DependenceCompletedNCT00223210Phase 4
6Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine DependencyCompletedNCT00280293Phase 4
7Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9CompletedNCT00015275Phase 4
8Quetiapine for Cocaine Use and CravingsCompletedNCT00232336Phase 4
9Pharmacotherapy and Intensive Treatment - 2CompletedNCT00000218Phase 4
10Effects of Modafinil in Methamphetamine DependenceCompletedNCT00751023Phase 4
11Seroquel Therapy for Substance Use Disorders Comorbid With SchizophreniaCompletedNCT00208143Phase 4
12The Maternal Lifestyle Study (MLS)CompletedNCT00059540Phase 4
13Brain Changes in Stimulant Dependent Subjects - 8CompletedNCT00000343Phase 4
14Bupropion for ADHD in Adolescents With Substance Use DisorderCompletedNCT00936299Phase 4
15Buprenorphine Maintenance vs. Detoxification in Prescription Opioid DependenceCompletedNCT00555425Phase 4
16Counseling for Primary Care Office-based BuprenorphineCompletedNCT00595764Phase 4
17A Study of VIVITROL in the Prevention of Re-arrest and Re-incarcerationCompletedNCT01453374Phase 4
18Neurobiological Adaptations and Pharmacological Interventions in Cocaine AddictionRecruitingNCT02626494Phase 4
19Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.RecruitingNCT03018236Phase 4
20Oxytocin and Cognitive Behavioral Therapy in Drug DependenceTerminatedNCT00975416Phase 4
21A PET Exploration of the Mechanism of Action of Dopamine Beta-hydroxylase Inhibition in Cocaine AddictsWithdrawnNCT02134002Phase 4
22Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1Unknown statusNCT00249691Phase 3
23Novel Pharmacotherapy for Dual DependenceUnknown statusNCT00448825Phase 3
24Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical TrialUnknown statusNCT01003496Phase 3
25Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine DependenceCompletedNCT01468012Phase 2, Phase 3
26Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1CompletedNCT00032929Phase 3
27Adaptive Treatment for Cocaine DependenceCompletedNCT01032135Phase 2, Phase 3
28Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine DependenceCompletedNCT00553319Phase 2, Phase 3
29Brain Imaging Study of the Effects of Modafinil in Cocaine AddictionCompletedNCT00701532Phase 3
30Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol DependenceCompletedNCT00167232Phase 3
31Dose Response Trial of Pergolide for Cocaine Dependence - 1CompletedNCT00000248Phase 3
32Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1CompletedNCT00218660Phase 3
33Vigabatrin for the Treatment of Cocaine DependencyCompletedNCT01281202Phase 2, Phase 3
34Cocaine Use Reduction With BuprenorphineCompletedNCT01402492Phase 2, Phase 3
35Cocaine/Crack and Reduction of Compulsion With BiperidenCompletedNCT01251393Phase 3
36Progesterone Treatment for Cocaine-dependent Women: A Pilot StudyCompletedNCT00632099Phase 2, Phase 3
37Clinical Neurobiology of Serotonin and AddictionCompletedNCT00732901Phase 2, Phase 3
38Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent PatientsCompletedNCT00495092Phase 2, Phase 3
39Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10CompletedNCT00000293Phase 3
40Smoking-Cessation and Stimulant Treatment (S-CAST)CompletedNCT01077024Phase 3
41Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1CompletedNCT00061087Phase 2, Phase 3
42Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/DependenceCompletedNCT00223236Phase 3
43Reengineering Methadone Treatment Study of Patient-centered Methadone TreatmentCompletedNCT01442493Phase 3
44An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.CompletedNCT00628927Phase 3
45Adaptive Treatment for Alcohol DependenceCompletedNCT02689674Phase 2, Phase 3
46The German Project of Heroin Assisted Treatment of Opiate Dependent PatientsCompletedNCT00268814Phase 3
47"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care."CompletedNCT01573416Phase 3
48Combination Therapy in Dual Diagnosis Bipolar Rapid CyclingCompletedNCT00221975Phase 3
49Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse DisorderCompletedNCT00194129Phase 3
50Methadone Maintenance for PrisonersCompletedNCT00378079Phase 3

Search NIH Clinical Center for Cocaine Dependence

Genetic Tests for Cocaine Dependence

About this section

Anatomical Context for Cocaine Dependence

About this section

MalaCards organs/tissues related to Cocaine Dependence:

36
Brain, Heart, Testes, Cortex, Prefrontal cortex, Pituitary, Thalamus

Publications for Cocaine Dependence

About this section

Articles related to Cocaine Dependence:

(show top 50)    (show all 602)
idTitleAuthorsYear
1
Netrin G1: its downregulation in the nucleus accumbens of cocaine-conditioned mice and genetic association in human cocaine dependence. (28074533)
2017
2
Kynurenic acid and alcohol and cocaine dependence: novel effects and multiple mechanisms? (27885412)
2017
3
Reply to: kynurenic acid and alcohol and cocaine dependence: novel effects and multiple mechanisms? (27896378)
2017
4
Topiramate for Cocaine Dependence: A Systematic Review and Meta-Analysis of Randomized Control Trials. (26826006)
2016
5
Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence. (28051838)
2016
6
Attenuated neural response to emotional cues in cocaine-dependence: a preliminary analysis of gender differences. (27441590)
2016
7
Psychiatric comorbidity in a sample of cocaine-dependent outpatients seen in the Community of Madrid drug addiction care network. (26990385)
2016
8
Successful classification of cocaine dependence using brain imaging: a generalizable machine learning approach. (27766943)
2016
9
A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment. (27449273)
2016
10
A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence. (26817621)
2016
11
Characterization of white matter integrity deficits in cocaine-dependent individuals with substance-induced psychosis compared with non-psychotic cocaine users. (26833821)
2016
12
Assessing the effects of cocaine dependence and pathological gambling using group-wise sparse representation of natural stimulus FMRI data. (27704410)
2016
13
Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial. (27046312)
2016
14
Just showing up is not enough: Homework adherence and outcome in cognitive-behavioral therapy for cocaine dependence. (27454780)
2016
15
Utility of Machine-Learning Approaches to Identify Behavioral Markers for Substance Use Disorders: Impulsivity Dimensions as Predictors of Current Cocaine Dependence. (27014100)
2016
16
Clinical differences between cocaine-dependent patients with and without antisocial personality disorder. (27839828)
2016
17
Psychotic symptoms associated with the use of dopaminergic drugs, in patients with cocaine dependence or abuse. (27009114)
2016
18
Effect of Continuing Care for Cocaine Dependence on HIV Sex-Risk Behaviors. (27224980)
2016
19
Cocaine-induced Psychosis and Brain-derived Neurothrophic Factor in Patients with Cocaine Dependence: Report of Two Cases. (26792050)
2016
20
Buprenorphinea88+a88Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study. (26948856)
2016
21
A Highly Polymorphic Copy Number Variant in the NSF Gene is Associated with Cocaine Dependence. (27498889)
2016
22
Antipsychotic medications for cocaine dependence. (26992929)
2016
23
Polysomnographic measures of sleep in cocaine dependence and alcohol dependence: Implications for age-related loss of slow wave, stage 3 sleep. (26749502)
2016
24
Cocaine dependence and thalamic functional connectivity: a multivariate pattern analysis. (27556009)
2016
25
Effective drug therapy for cocaine dependence: a milestone. (27015910)
2016
26
Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence. (27394932)
2016
27
Dissociable Effects of Cocaine-Dependence on Reward Processes: The Role of Acute Cocaine and Craving. (27545986)
2016
28
Crack-cocaine dependence and aging: effects on working memory. (27111700)
2016
29
Neurofunctional Reward Processing Changes in Cocaine Dependence During Recovery. (26792441)
2016
30
Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users. (27499362)
2016
31
Psychostimulant drugs for cocaine dependence. (27670244)
2016
32
Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence. (26777774)
2016
33
Dopamine agonists for the treatment of cocaine dependence. (26014366)
2015
34
Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial. (25922424)
2015
35
Anticonvulsants for cocaine dependence. (25882271)
2015
36
In the face of threat: neural and endocrine correlates of impaired facial emotion recognition in cocaine dependence. (26080087)
2015
37
A Randomized Placebo-Controlled Trial of Targeted Prefrontal Cortex Modulation with Bilateral tDCS in Patients with Crack-Cocaine Dependence. (26065432)
2015
38
Deep Brain Stimulation for Refractory Cocaine Dependence. (26235303)
2015
39
Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence. (26506053)
2015
40
Increased corticolimbic connectivity in cocaine dependence versus pathological gambling is associated with drug severity and emotion-related impulsivity. (25818325)
2015
41
A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO. (26164205)
2015
42
Changes in brain-derived neurotrophic factor (BDNF) during abstinence could be associated with relapse in cocaine-dependent patients. (25592977)
2015
43
Effect of Patient Choice in an Adaptive Sequential Randomization Trial of Treatment for Alcohol and Cocaine Dependence. (26214544)
2015
44
Effect of cocaine dependence on brain connections: clinical implications. (26512421)
2015
45
Self-reported impulsivity is negatively correlated with amygdalar volumes in cocaine dependence. (26187551)
2015
46
Impaired Bayesian learning for cognitive control in cocaine dependence. (25869543)
2015
47
Self-reported cue-induced physical symptoms of craving as an indicator of cocaine dependence. (26541796)
2015
48
Integrative Bayesian Analysis of Neuroimaging-Genetic Data with Application to Cocaine Dependence. (26484829)
2015
49
Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. (25697913)
2015
50
A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder. (25998279)
2015

Variations for Cocaine Dependence

About this section

Expression for genes affiliated with Cocaine Dependence

About this section
Search GEO for disease gene expression data for Cocaine Dependence.

Pathways for genes affiliated with Cocaine Dependence

About this section

GO Terms for genes affiliated with Cocaine Dependence

About this section

Cellular components related to Cocaine Dependence according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1axon terminusGO:004367910.4DRD2, OPRK1, PDYN
2perikaryonGO:004320410.2DRD2, OPRK1, OPRM1
3secretory granule lumenGO:00347749.7DBH, POMC
4integral component of plasma membraneGO:00058879.3DRD2, DRD3, OPRK1, OPRM1, SLC6A3, SLC6A4
5acetylcholine-gated channel complexGO:00058929.3CHRNA3, CHRNA5, CHRNB3
6neuron projectionGO:00430059.3CHRNB3, OPRK1, OPRM1, SLC6A3, SLC6A4
7neuronal cell bodyGO:00430259.0CHRNA3, CHRNA5, OPRK1, PDYN, SLC6A3
8dendriteGO:00304258.6CHRNA3, CHRNA5, DRD2, OPRK1, OPRM1, PDYN
9plasma membraneGO:00058866.5CHRNA3, CHRNA5, CHRNB3, DRD2, DRD3, OPRK1

Biological processes related to Cocaine Dependence according to GeneCards Suite gene sharing:

(show all 50)
idNameGO IDScoreTop Affiliating Genes
1adenohypophysis developmentGO:002198410.7DRD2, SLC6A3
2acid secretionGO:004671710.7DRD2, DRD3
3adenylate cyclase-inhibiting dopamine receptor signaling pathwayGO:000719510.7DRD2, DRD3
4arachidonic acid secretionGO:005048210.7DRD2, DRD3
5dopamine metabolic processGO:004241710.7DRD2, DRD3
6dopamine receptor signaling pathwayGO:000721210.7DRD2, DRD3
7G-protein coupled receptor internalizationGO:000203110.6DRD2, DRD3
8negative regulation of blood pressureGO:004577610.6DRD2, DRD3
9negative regulation of dopamine receptor signaling pathwayGO:006016010.6DRD2, DRD3
10negative regulation of protein secretionGO:005070910.6DRD2, DRD3
11positive regulation of renal sodium excretionGO:003581510.6DRD2, DRD3
12regulation of cAMP metabolic processGO:003081410.6DRD2, DRD3
13regulation of dopamine secretionGO:001405910.6DRD2, DRD3
14regulation of dopamine uptake involved in synaptic transmissionGO:005158410.6DRD2, DRD3
15regulation of locomotion involved in locomotory behaviorGO:009032510.6DRD2, DRD3
16monoamine transportGO:001584410.6SLC6A3, SLC6A4
17associative learningGO:000830610.6DBH, DRD2
18dopamine catabolic processGO:004242010.5DBH, SLC6A3
19response to iron ionGO:001003910.5DRD2, SLC6A3
20response to histamineGO:003477610.5DRD2, DRD3
21adenylate cyclase-activating dopamine receptor signaling pathwayGO:000719110.5DRD3, OPRM1
22maternal behaviorGO:004271110.5DBH, OPRK1
23adenylate cyclase-inhibiting opioid receptor signaling pathwayGO:003163510.4OPRK1, OPRM1
24synaptic transmission, dopaminergicGO:000196310.4DRD2, DRD3
25eating behaviorGO:004275510.4OPRK1, OPRM1
26estrous cycleGO:004484910.4OPRK1, OPRM1
27opioid receptor signaling pathwayGO:003800310.4OPRK1, OPRM1
28prepulse inhibitionGO:006013410.4DRD2, DRD3, SLC6A3
29regulation of sensory perception of painGO:005193010.4OPRK1, OPRM1
30regulation of multicellular organism growthGO:004001410.4DRD3, PRL
31behavioral response to cocaineGO:004814810.3DRD2, DRD3, OPRK1
32response to amphetamineGO:000197510.2DBH, DRD2, DRD3
33negative regulation of adenylate cyclase activityGO:000719410.2DRD2, DRD3, OPRM1
34behavioral response to ethanolGO:004814910.1DBH, DRD2, OPRM1
35neuromuscular synaptic transmissionGO:000727410.0CHRNA5, CHRNB3
36excitatory postsynaptic potentialGO:00600799.9CHRNA3, OPRM1
37sensory perceptionGO:00076009.9OPRK1, OPRM1, PDYN
38behavioral response to nicotineGO:00350959.9CHRNA3, CHRNA5
39chemical synaptic transmission, postsynapticGO:00995659.8CHRNA5, CHRNB3, DRD2
40response to morphineGO:00432789.7DRD2, DRD3, OPRK1, OPRM1
41neuropeptide signaling pathwayGO:00072189.7OPRK1, OPRM1, PDYN, POMC
42visual learningGO:00085429.6DBH, DRD2, DRD3
43response to cocaineGO:00422209.5DRD2, DRD3, OPRK1, OPRM1, SLC6A3
44response to ethanolGO:00454719.5DRD2, DRD3, OPRK1, OPRM1, SLC6A3
45response to nicotineGO:00350949.3CHRNA5, CHRNB3, DRD2, SLC6A3
46cation transmembrane transportGO:00986559.2CHRNA3, CHRNA5, CHRNB3
47response to drugGO:00424939.1CHRNA3, DRD2, DRD3, SLC6A3, SLC6A4
48synaptic transmission, cholinergicGO:00072719.0CHRNA3, CHRNA5, CHRNB3
49chemical synaptic transmissionGO:00072688.9CHRNA5, DBH, OPRK1, OPRM1, PDYN, SLC6A4
50locomotory behaviorGO:00076268.4CHRNA3, DBH, DRD2, DRD3, OPRK1, OPRM1

Molecular functions related to Cocaine Dependence according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1dopamine neurotransmitter receptor activityGO:000495210.5DRD2, DRD3
2dopamine neurotransmitter receptor activity, coupled via Gi/GoGO:000159110.5DRD2, DRD3
3monoamine transmembrane transporter activityGO:000850410.4SLC6A3, SLC6A4
4dopamine bindingGO:003524010.3DRD2, DRD3, SLC6A3
5neuropeptide bindingGO:004292310.1OPRK1, OPRM1
6neuropeptide hormone activityGO:000518410.0PDYN, POMC
7opioid receptor activityGO:00049859.7OPRK1, OPRM1
8acetylcholine bindingGO:00421669.1CHRNA3, CHRNA5, CHRNB3
9acetylcholine receptor activityGO:00154649.1CHRNA3, CHRNA5, CHRNB3
10acetylcholine-activated cation-selective channel activityGO:00048899.1CHRNA3, CHRNA5, CHRNB3
11ligand-gated ion channel activityGO:00152769.0CHRNA3, CHRNA5, CHRNB3
12drug bindingGO:00081448.8CHRNA3, CHRNB3, DRD2, DRD3, SLC6A3

Sources for Cocaine Dependence

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet